Mayo Clinic

Risk for chronic kidney disease even more critical due to COVID-19 pandemic

Newswise — ROCHESTER, Minn. — An estimated 1 in 10 people worldwide have chronic kidney disease, but most of them don't know it. That lack of awareness is especially concerning because people with chronic kidney disease who are infected with COVID-19 are at higher risk for serious illness.

It is important that people understand their risk for developing chronic kidney disease and take steps to prevent it, says Andrew Bentall, M.B., Ch.B., M.D., a Mayo Clinic nephrologist.

"Managing risk factors such as high blood pressure, diabetes and obesity will reduce the chances of developing kidney disease," Dr. Bentall says. "Once an individual has chronic kidney disease, there mostly is no current cure. But early diagnosis and treatment can help prevent kidney failure and the need for a kidney transplant."

Thursday, March 11, is World Kidney Day. To raise awareness, Mayo Clinic will light the Plummer Building in Rochester, Mayo Clinic Hospital in Arizona and the main entrance to Mayo Clinic in Florida orange. Nearly 108,000 people are on the waitlist in the U.S. for a lifesaving kidney transplant, according to the Organ Procurement and Transplantation Network.

Kidneys play a critical role in the body, filtering waste and excess fluid from the body, which are excreted in urine. Chronic kidney disease describes the gradual loss of kidney function.

Below are some key facts to know about chronic kidney disease:

  • Some racial and ethnic populations are at higher risk for kidney disease. African Americans, Hispanics, Asian Americans and Native Americans are more likely to develop chronic kidney disease. For example, African Americans are three times more likely to have kidney failure, according to the National Kidney Foundation.
  • Women are more likely to experience kidney failure. Chronic kidney disease is more common in women than men, with an estimated 15% of women being diagnosed with it versus 12% of men, according to the Centers for Disease Control and Prevention.
  • Diabetes, high blood pressure and obesity are key risk factors. People with diabetes and high blood pressure, and those who are obese, are all at higher risk for developing chronic kidney disease. Other risk factors include smoking, heart disease, a family history of the disease, older age and abnormal kidney structure.
  • There may be few signs and symptoms in early stages of chronic kidney disease. Symptoms can include nausea, vomiting, loss of appetite, fatigue, sleep problems and changes in urine output. Sometimes people experience shortness of breath, swelling of feet and ankles, muscle twitches and cramps, persistent itching and chest pain.
  • Quitting smoking and losing weight can help prevent kidney disease. Smoking can damage the kidneys and worsen existing kidney damage. Maintaining a healthy weight also can help reduce the risk for kidney disease. It is also critical that people manage chronic conditions such as high blood pressure and diabetes.

Sandra Herrmann, M.D., a Mayo Clinic nephrologist, has a key piece of advice for people at high risk of developing chronic kidney disease. "Don't wait to talk to your doctor about kidney health," Dr. Herrmann says. "There are simple blood and urine tests that can detect chronic kidney disease. The earlier kidney failure is diagnosed, the better the chance of preventing kidney failure and reducing the risk of other complications such as heart attacks and strokes."

###

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.



Filters close

Showing results

110 of 5809
Newswise: 267646_web.jpg
Released: 11-Jun-2021 2:10 PM EDT
Saliva can be more effective than nasopharyngeal swabs for COVID-19 testing
Elsevier

The collection of nasopharyngeal swab (NPS) samples for COVID-19 diagnostic testing poses challenges including exposure risk to healthcare workers and supply chain constraints.

Released: 11-Jun-2021 1:25 PM EDT
Physical Activity May Curb Health Care Worker Burnout
University of Georgia

More physical activity programming could mitigate the effects of stress and improve worker mental and emotional health.

Newswise: AI Predicts How Patients with Viral Infections, Including COVID-19, Will Fare
9-Jun-2021 6:05 PM EDT
AI Predicts How Patients with Viral Infections, Including COVID-19, Will Fare
University of California San Diego Health

UC San Diego School of Medicine researchers discovered gene expression patterns associated with pandemic viral infections, providing a map to help define patients’ immune responses, measure disease severity, predict outcomes and test therapies — for current and future pandemics.

Released: 10-Jun-2021 5:35 PM EDT
Senolíticos reducen síntomas de COVID-19 en estudios preclínicos
Mayo Clinic

Los investigadores de Mayo Clinic y sus colegas de la Universidad de Minnesota demostraron que la COVID-19 exacerba las consecuencias nocivas de las células senescentes en el cuerpo. En estudios preclínicos, los fármacos senolíticos descubiertos en Mayo redujeron considerablemente la inflamación, la enfermedad y la mortalidad debida a la infección por covid en ratones ancianos. Los resultados se publican en la revista Science.

Released: 10-Jun-2021 5:30 PM EDT
Senolíticos reduzem os sintomas de COVID-19 em estudos pré-clínicos
Mayo Clinic

Os pesquisadores da Mayo Clinic e colegas da Universidade de Minnesota mostraram que o COVID-19 intensifica o impacto prejudicial das células senescentes no corpo. Em estudos pré-clínicos, os medicamentos senolíticos descobertos na Mayo reduziram significativamente a inflamação, a gravidade da doença e a mortalidade da infecção por COVID em camundongos mais velhos. Essas conclusões foram publicadas na revista Science.

Newswise: FresnoSTateVaxImage2.jpg
Released: 10-Jun-2021 5:25 PM EDT
CSU Campuses Join COVID-19 College Vaccine Challenge
California State University (CSU) Chancellor's Office

The CSU pledges to be a Vaccine Champion University as part of new White House effort aimed at increasing vaccinations for younger Americans.

Released: 10-Jun-2021 5:05 PM EDT
الأدوية المحللة للشيخوخة تقلل من أعراض فيروس كورونا المستجد (كوفيد-19) في الدراسات ما قبل السريرية
Mayo Clinic

أظهر باحثو مايو كلينك وزملاؤهم في جامعة مينيسوتا أن فيروس كورونا المستجد (كوفيد-19) يفاقم التأثير الضار للخلايا الشائخة في الجسم. ففي الدراسات ما قبل السريرية، قللت الأدوية المحللة لالشيخوخة التي تم اكتشافها في مايو بشكل كبير من الالتهاب والمرض والوفيات الناجمة عن عَدوى فيروس كورونا المستجد في الفئران الأكبر سنًا. النتائج منشورة في مجلة ساينس.

7-Jun-2021 7:05 AM EDT
Study Examines the Effects of COVID-19 on Human Kidney Cells
American Society of Nephrology (ASN)

• The virus that causes COVID-19 can infect and replicate in human kidney cells, but this does not typically lead to cell death. • Kidney cells that already have features of injury may be more easily infected and develop additional injury.

Released: 10-Jun-2021 4:55 PM EDT
抗衰老药物在临床前研究中减少COVID-19症状。
Mayo Clinic

妙佑医疗国际(Mayo Clinic)的研究人员和明尼苏达大学的同事表明,COVID-19(2019冠状病毒病)加剧了体内衰老细胞的破坏性影响。在临床前研究中,妙佑医疗国际研发的抗衰老药物显著降低了老年实验鼠因COVID(冠状病毒病)感染引起的炎症、疾病和死亡率。该研究结果已发表在《科学》期刊中。

Newswise: blobid0_1623274320110.jpg
Released: 10-Jun-2021 4:45 PM EDT
How does COVID-19 affect patients with cancer? Largest U.S. study shares first results
University of Alabama at Birmingham

New findings include a significant increase in risk of death among patients who had recently had chemotherapy.


Showing results

110 of 5809

close
2.20377